Gut Microbiome and Serum Metabolome Alterations in ADHD Patients (ADHD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03447223|
Recruitment Status : Not yet recruiting
First Posted : February 27, 2018
Last Update Posted : March 1, 2018
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||400 participants|
|Official Title:||Gut Microbiome and Serum Metabolome Alterations in Attention-deficit/Hyperactivity Disorder Patients|
|Estimated Study Start Date :||February 28, 2018|
|Estimated Primary Completion Date :||February 27, 2020|
|Estimated Study Completion Date :||February 27, 2020|
The children 3-15 years old with ADHD. Diagnoses of the children with ADHD were made in Xijing Hospital according to criteria described in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Children with ADHD had an IQ score above 70.
Age- and gender- matched healthy 3-15 years old children.
- ADHD-associated gut microbial species alterations [ Time Frame: 2018-2019 ]Gut metagenome analysis with fecal samples
- ADHD-associated circulating metabolites alterations [ Time Frame: 2018-2019 ]Circulation metabonomics analysis with serum samples
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03447223
|Contact: Yan Li, M.D./Ph.D.||+firstname.lastname@example.org|
|Contact: Anqi Yin, M.D.||+email@example.com|
|Principal Investigator:||Lize Xiong, M.D./Ph.D.||Professor and President, Xijing Hospital|